Issue 24 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

21

No.

24

June 16, 1995Jun 16, 1995

Free

DOWNLOAD THE PDF

Cooperative Groups Advised To Plan For Future Of Less Funding from NCI

In Brief: General Motors Cancer Research Foundation Prizewinners: Brock, Li, Fraumeni, Harlow

ODAC Recommends Ethyol, DaunoXome For FDA Approval

ORI Clears Los Angeles Physician Of Misconduct In NSABP Participation

Cancer Panel Urges Improved Funding For Basic Science

FDA, NIH Streamline Approvals For Gene Therapy Studies

Report Criticizes NIH Grant Review

NIH Policy On Diversity In Sponsored Meetings

Recent Issues

Volume 51 | Issue 45 - December 12, 2025

Volume 51 | Issue 44 - December 05, 2025

Volume 51 | Issue 43 - November 21, 2025

Volume 51 | Issue 42 - November 14, 2025

Volume 51 | Issue 41 - November 07, 2025

Volume 51 | Issue 40 - October 31, 2025